【摘要】 目的 觀察腹腔鏡手術(shù)聯(lián)合孕三烯酮治療子宮內(nèi)膜異位癥合并不孕的療效及不同評分系統(tǒng)對妊娠結(jié)局的預(yù)測價值?！》椒ā』仡櫺苑治?004年1月-2006年12月收治的97例子宮內(nèi)膜異位癥合并不孕患者的臨床病理資料，統(tǒng)計其術(shù)后妊娠率及活產(chǎn)率。 結(jié)果 術(shù)后1年內(nèi)與1~2年的妊娠率與活產(chǎn)率比較，差異均無統(tǒng)計學(xué)意義（Pgt;0.05）。根據(jù)美國生育協(xié)會1985年修訂的子宮內(nèi)膜異位癥分期標(biāo)準(zhǔn)（r-AFS）進(jìn)行分期，各期患者術(shù)后妊娠率差異無統(tǒng)計學(xué)意義（Pgt;0.05）；但隨著分期升高，活產(chǎn)率逐漸下降（Plt;0.05）。子宮內(nèi)膜異位癥生育指數(shù)（EFI）評分越高，其妊娠率和活產(chǎn)率也越高（Plt;0.05）?！〗Y(jié)論 子宮內(nèi)膜異位癥患者腹腔鏡手術(shù)后聯(lián)用孕三烯酮可能會提高遠(yuǎn)期妊娠率。r-AFS分期對妊娠結(jié)局的預(yù)測有一定局限性，而EFI具有較好的預(yù)測性?！続bstract】 Objective To evaluate the therapeutic effectiveness of laparoscopic surgery combined with gestrinone treatment in the infertile women with endometriosis (EM), and the value of different score systems to predict gestational outcome. Methods We retrospectively analyzed the clinical data of 97 infertile women with EM who were treated in our hospital from January 2004 to December 2006, and collected their pregnancy rate (PR) and live birth rate (LBR) after operation. Results There was no significant difference of PR and LBR within the 1st year and between the 1st and the 2nd year (Pgt;0.05). There was no significant difference of PR among women of various stages of EM based on the 1985 edition of risk stratification for patients with EM put forward by American Fertility Society (r-AFS) (Pgt;0.05), but the LBR decreased with the raising of the stages (Plt;0.05). The endometriosis fertility index (EFI) was positively correlated with PR and LBR (Plt;0.05). Conclusion Laparoscopic surgery combined with gestrinone may increase the long-term pregnancy rate of women with EM. R-AFS classification is limited in predicting the gestational outcome of women with EM, while EFI achieves a better result.